Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

44 ARSENIC
(1993): Alain G+, Int J Dermatol 32, 899 (passim)
(1993): Sass U+, Dermatology 186, 303
(1993): Ziegler A+, Proc Natl Acad
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 236 (passim)
(1987): Chakraborty AK+, Indian J Med Res 85, 326
(1986): Munzberger H+, Z Arztl Fortbild Jena (German) 80, 985
(1985): Kastl J+, Dermatol Monatsschr (German) 171, 158
(1984): Schroeder P+, Fortschr Med (German) 102, 1128
(1980): Weiss J+, Hautarzt (German) 31, 654
Palmar–plantar erythema
Palmar–plantar hyperhidrosis
(2000): Gerdssn R+, Acta Derm Venereol 80, 292
Palmar–plantar hyperkeratosis
(2005): Fumal I+, Rev Med Liege 60(4), 217
(2002): Hall AH, Toxicol Lett 128(1), 69
(2000): Gerdsen R+, Acta Derm Venereol 80, 292
(1998): Tsuruta D+, Br J Dermatol 139, 291
(1997): Ohnishi Y+, JDermatol24, 310
(1996): Maloney ME, Dermatol Surg 22, 301 (passim)
(1996): Person JR, Cutis 58, 65
(1994): Hsieh LL+, Cancer Lett 86, 59
(1993): Alain G+, Int J Dermatol 32, 899 (passim)
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 236 (passim)
(1989): Koh E+, Eur Urol 16, 398
(1989): Shannon RL+, Hum Toxicol 8, 99
(1988): Ismail R+, JDermatol15, 65
(1983): Heddle R+, Chest 84, 776
(1982): Ohyama K, Dermatologica 164, 161
(1982): Rosen T+, JAmAcadDermatol7, 364
Palmar–plantar punctate keratoses
(1996): Maloney ME, Dermatol Surg 22, 301 (passim)
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 236 (passim)
Parapsoriasis
Photosensitivity
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 236 (passim)
Pigmentation
(2004): Kwong YL, Expert Opin Drug Saf 3(6), 589
(2002): Hall AH, Toxicol Lett 128(1), 69
(2002): Liu J+, Environ Health Perspect 110(2), 119
(2002): Park JY+, JDermatol29(7), 446
(2001): Kurokawa M+, Arch Dermatol 137, 102
(2001): Yu HS+, JDermatol28(11), 628
(1999): Tondel M+, Environmental Health Perspectives 107, 727
(1998): Guha Mazumder DN+, Int J Epidemiol 27, 871
(1996): Maloney ME, Dermatol Surg 22, 301 (passim)
(1993): Alain G+, Int J Dermatol 32, 899 (passim)
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 236 (passim)
(1989): Shannon RL+, Hum Toxicol 8, 99
(1981): Granstein RD+, JAmAcadDermatol5, 1 (bronze)
Pityriasis rosea (from organic arsenic)
(1988): Bork K, CutaneousSideEffectsofDrugsWB Saunders,
169
Pruritus
Psoriasis
Purpura
(1988): Bork K, CutaneousSideEffectsofDrugsWB Saunders,
191
Rash (sic)
(2004): Kwong YL, Expert Opin Drug Saf 3(6), 589
Raynaud’s phenomenon
(2002): Hall AH, Toxicol Lett 128(1), 69
Squamous cell carcinoma
(2005): Fumal I+, Rev Med Liege 60(4), 217
(2002): Centeno JA+, Environ Health Perspect 110 Suppl 5, 883
(chronic exposure)
(2002): Park JY+, JDermatol29(7), 446
(2001): Guo HR+, Cancer Causes Control 12(10), 909
(1998): Wong SS+, JAmAcadDermatol38(2 Pt 1), 179
(1996): Maloney ME, Dermatol Surg 22, 301 (passim)
(1993): Alain G+, Int J Dermatol 32, 899 (passim)
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 236 (passim)
(1989): Shannon RL+, Hum Toxicol 8, 99
(1988): Ismail R+, JDermatol15, 65
(1988): Scholz S+, Z Arztl Fortbild Jena (German) 82, 1201
Stevens–Johnson syndrome
(1990): Vassileva S+, Int J Dermatol 29, 381
Ulcerations
(2002): Liu J+, Environ Health Perspect 110(2), 119
Urticaria
Vitiligo
(1989): Bickley LK+, NJMed86, 377
Mucosal
Oral mucosal eruption (8%)
Oral pigmentation
(1988): Bork K, CutaneousSideEffectsofDrugsWB Saunders,
288
Stomatitis
Hair
Hair – alopecia
(1993): Alain G+, Int J Dermatol 32, 899 (passim)
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 236 (passim)
(1988): Bork K, CutaneousSideEffectsofDrugsWB Saunders,
249
Nails
Nails – leukonychia
(1988): Bork K, CutaneousSideEffectsofDrugsWB Saunders,
262
Nails – Mees’ lines
(1993): Alain G+, Int J Dermatol 32, 899 (passim)
(1993): Sass U+, Dermatology 186, 303
Nails – pigmentation
(1988): Bork K, CutaneousSideEffectsofDrugsWB Saunders,
261
Other
Death
(2003): Uede K+, Br J Dermatol 149(4), 757
Gangrene
(2002): Alam MG+, IntJEnvironHealthRes12(3), 235 (chronic
exposure)
Gynecomastia
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 237 (passim)
Hepatotoxicity
(2004): Kwong YL, Expert Opin Drug Saf 3(6), 589
Tumors (malignant)
(2001): Kurokawa M+, Arch Dermatol 137, 102